We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$164M
AUM Growth
+$77.1M
Cap. Flow
+$71.4M
Cap. Flow %
43.55%
Top 10 Hldgs %
45.49%
Holding
112
New
48
Increased
28
Reduced
19
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUFD icon
101
FT Vest Fund of Deep Buffer ETFs
BUFD
$1.92B
-184,380
Closed -$3.52M
FPE icon
102
First Trust Preferred Securities and Income ETF
FPE
$6.36B
-49,711
Closed -$834K
FREL icon
103
Fidelity MSCI Real Estate Index ETF
FREL
$1.52B
-8,808
Closed -$211K
GOOGL icon
104
Alphabet (Google) Class A
GOOGL
$4.23T
-8,498
Closed -$813K
META icon
105
Meta Platforms (Facebook)
META
$1.64T
-1,747
Closed -$237K
PRU icon
106
Prudential Financial
PRU
$41.4B
-7,611
Closed -$653K
RSP icon
107
Invesco S&P 500 Equal Weight ETF
RSP
$96.4B
-19,226
Closed -$2.45M
SDVY icon
108
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.4B
-120,832
Closed -$2.79M
TIP icon
109
iShares TIPS Bond ETF
TIP
$14.5B
-19,329
Closed -$2.03M
TSLA icon
110
Tesla
TSLA
$1.43T
-4,660
Closed -$1.24M
XLK icon
111
State Street Technology Select Sector SPDR ETF
XLK
$114B
-8,216
Closed -$488K
XMMO icon
112
Invesco S&P MidCap Momentum ETF
XMMO
$7.23B
-57,437
Closed -$4.01M

Similar funds

Prostatis Group's Q4 2022 Portfolio in Review

As of Q4 2022, Prostatis Group held 112 positions worth $164M, up 89% from $86.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prostatis Group deployed $71.4M of net new capital in Q4 2022, opening 48 new positions and adding to 28 existing holdings. Its largest new stake was Vanguard Value ETF: 120,222 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 3.6% of assets, down from 6% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Invesco S&P 500 GARP ETF, an estimated $5.24M trimmed.

  • Prostatis Group's largest Q4 2022 buy was Vanguard Value ETF: 120,222 shares worth $16.9M.
  • Prostatis Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2022, an estimated $2.47M increase.
  • Prostatis Group's biggest Q4 2022 reduction was Invesco S&P 500 GARP ETF, cutting an estimated $5.24M.
  • Prostatis Group fully exited Invesco S&P MidCap Momentum ETF in Q4 2022, selling an estimated $4.01M.
  • Prostatis Group's ten largest holdings make up 45% of its $164M portfolio in Q4 2022.
  • Prostatis Group opened 48 new positions and closed 15 in Q4 2022.
  • Prostatis Group's portfolio value rose 89% quarter-over-quarter to $164M.

Based on Prostatis Group's 13F filing for Q4 2022, filed 23 Mar 2023.